Market OverviewAs understanding of HPV's role in cancer development deepens, research and diagnostic tools built around the E6 oncoprotein are gaining commercial traction. The Human Papillomavirus Protein E6 Market was valued at 700 USD Million in 2024 and is projected to grow to 1,200 USD Million by 2035, at a CAGR of 5.6%. Current Market LandscapeThe market spans research laboratories,...